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Abstract
Aims/hypothesis Variants close to the VPS13C/C2CD4A/C2CD4B locus are associated with altered risk of type 2 diabetes in
genome-wide association studies. While previous functional work has suggested roles for VPS13C and C2CD4A in disease
development, none has explored the role of C2CD4B.
Methods CRISPR/Cas9-induced globalC2cd4b-knockout mice and zebrafish larvae with c2cd4a deletion were used to study the
role of this gene in glucose homeostasis. C2 calcium dependent domain containing protein (C2CD)4A and C2CD4B constructs
tagged with FLAG or green fluorescent protein were generated to investigate subcellular dynamics using confocal or near-field
microscopy and to identify interacting partners by mass spectrometry.
Results Systemic inactivation of C2cd4b in mice led to marked, but highly sexually dimorphic changes in body weight and
glucose homeostasis. Female C2cd4b mice displayed unchanged body weight compared with control littermates, but abnormal
glucose tolerance (AUC, p = 0.01) and defective in vivo, but not in vitro, insulin secretion (p = 0.02). This was associated with a
marked decrease in follicle-stimulating hormone levels as compared with wild-type (WT) littermates (p = 0.003). In sharp
contrast, male C2cd4b null mice displayed essentially normal glucose tolerance but an increase in body weight (p < 0.001)
and fasting blood glucose (p = 0.003) after maintenance on a high-fat and -sucrose diet vs WT littermates. No metabolic
disturbances were observed after global inactivation of C2cd4a in mice, or in pancreatic beta cell function at larval stages in
C2cd4a null zebrafish. Fasting blood glucose levels were also unaltered in adult C2cd4a-null fish. C2CD4B and C2CD4A were
partially localised to the plasma membrane, with the latter under the control of intracellular Ca2+. Binding partners for both
included secretory-granule-localised PTPRN2/phogrin.
Conclusions/interpretation Our studies suggest thatC2cd4bmay act centrally in the pituitary to influence sex-dependent circuits
that control pancreatic beta cell function and glucose tolerance in rodents. However, the absence of sexual dimorphism in the
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impact of diabetes risk variants argues for additional roles for C2CD4A or VPS13C in the control of glucose homeostasis in
humans.
Data availability The datasets generated and/or analysed during the current study are available in the Biorxiv repository (www.
biorxiv.org/content/10.1101/2020.05.18.099200v1). RNA-Seq (GSE152576) and proteomics (PXD021597) data have been
deposited to GEO (www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE152576) and ProteomeXchange (www.ebi.ac.uk/pride/
archive/projects/PXD021597) repositories, respectively.
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Abbreviations
C2CD C2 calcium dependent domain containing protein
E2 Oestradiol
eQTL Expression quantitative trait locus
ER Endoplasmic reticulum
FSH Follicle-stimulating hormone
GFP Green fluorescent protein
GWAS Genome-wide association study
HFD High-fat and -sucrose diet
IA-2 Insulinoma-associated protein 2
IMPC International Mouse Phenotyping Consortium
KREBH HEPES-buffered Krebs-Ringer medium
LH Luteinising hormone
PTPRN Receptor-type tyrosine-protein phosphatase-like N
RC Regular chow
Syt1 Synaptotagmin-1
TIRF Total internal reflection of fluorescence
WT Wild-type
Introduction
Type 2 diabetes risk is the product of both environmental and
genetic factors. More than 200 loci have now been described
as affecting the diabetes risk score [1]. While most of these
impact insulin secretion [2], the identified variants usually lie
within or between neighbouring genes and in only a few cases
have the causal gene(s) been firmly established [3, 4].
Chromosome 15q hosts a risk locus close to the VPS13C,
C2CD4A and C2CD4B genes [5], which is associated with
impaired proinsulin processing. Deletion of Vps13c (which
encodes a lipid transporter [6]) selectively from the pancreatic
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beta cell [7] has little effect on glucose homeostasis in the
mouse. This finding argues that the other genes at this locus
contribute towards the effect(s) of risk variants in humans.
Previous expression quantitative trait locus (eQTL) studies
have demonstrated altered expression of VPS13C and
C2CD4A [7], as well as C2CD4B [8], in islets from individ-
uals carrying risk alleles. Recently, Kycia et al [9] reported
that expression of C2CD4B, but not C2CD4A or VPS13C,
was affected by risk alleles. However, the direction of effects
of risk alleles differed between the reports, with expression
lowered uniquely in females in the study of Mehta et al [7] but
increased in the study by Kycia et al [9]. However, both of
these studies involved relatively small sample numbers. These
limitations emphasise the need for interventional studies
involving gene inactivation in tractable model systems, such
as rodents or fish, as an alternative means of understanding the
roles of these genes in metabolic homeostasis.
C2CD4A and C2CD4B (also called NLF1 and NLF2) [10]
encode low molecular mass (39 kDa) proteins of presently
unknown function. Unlike the homologous C2CD4C gene
(expressed from a distinct locus on chromosome 19 in Homo
sapiens), neither C2 calcium dependent domain containing
protein (C2CD)4A nor C2CD4B possess a canonical Ca2+/phos-
pholipid-binding C2-domain [11]. A partly functional Ca2+-
binding domain may be present in C2CD4B (see electronic
supplementary material [ESM] Fig.1). Given the essential role
for Ca2+ in the control of insulin and other hormone secretion
[12], an interaction with Ca2+ might provide a means through
which C2CD4A or C2CD4B influence these processes.
Originally described in endothelial cells as having a largely
nuclear distribution, and inducible by cytokines [10], the role
of C2CD4B has not been explored previously in beta cells or
other metabolically relevant cell types. Nonetheless, silencing
of the single homologous C2cd4a/b gene in the zebrafish
(Danio rerio) led to a decrease in beta cell mass [13]. In
contrast, silencing of the Drosophila melanogaster C2CD4A
homologue, spenito (also known as nito), increased circulat-
ing levels of the insulin-like molecule IIp2HF [14].
Inactivation of C2cd4c has no detectable effect on pancreatic
development in mice [11].
A recent study [15] has indicated that regulation of
C2cd4a expression in islets by forkhead box O1
(FOXO1) may be important for the control of insulin secre-
tion. Thus, animals inactivated selectively in the beta cell
for C2cd4a displayed abnormal insulin secretion in
response to exposure to glucose plus arginine (the effects
on secretion stimulated by glucose alone were not report-
ed), as well as glucose intolerance in vivo and abnormal
expression of beta cell signature and ‘disallowed’ genes
[16]. However, these studies used the Ins2-dependent rat
insulin promoter (RIP) to drive Cre expression, a strategy
complicated by off-target recombination and ectopic
expression of human growth hormone [17].
Here, we use the more direct approach of inactivating
C2cd4b and C2cd4a globally in the mouse, and of deleting
their homologue, C2cd4a, in the developing zebrafish
(D. rerio), to explore the role of these genes in glucose
homeostasis.
Methods
For detailed Methods and the reagents list, please refer to the
ESM Methods.
Mouse generationC2cd4a (C2cd4a-Del1724-EM1-B6N) and
C2cd4b (C2cd4bem2Wtsi) mouse strains were generated at the
International Mouse Phenotyping Consortium (IMPC; www.
mousephenotype.org/data/genes/MGI:3645763 and www.
mousephenotype.org/data/genes/MGI:1922947, respectively;
accessed November 2020), using CRISPR/Cas9. In vitro
fertilisation was performed into super-ovulated C57BL/6
females, producing mixed B6N/B6J offspring, which were
subsequently inter-crossed. Lean and fat mass were measured
using an EchoMRI Quantitative Whole Body Composition
analyser (Zinsser Analytic, USA) on unanaesthetised animals.
The high-fat and -sucrose diet (HFD) contained 58% fat and
25% carbohydrate (catalogue no. D12331; Research Diets,
New Brunswick, NJ, USA), given from 6 weeks of age.
Glucose homeostasis Animals were fasted overnight prior to
experiments. For IPGTTs, glucose (1 g/kg body weight) was
injected into the abdomen. In OGTTs, glucose (2 g/kg body
weight) was administered directly into the gut via oral gavage.
Blood glucose levels were recorded using an automatic
glucometer (Accucheck; Roche Diagnostics, Burgess Hill,
UK). For insulin tolerance tests, animals were fasted for 5 h
prior to experiments. Insulin was injected into the abdomen:
Male and female mice (both C2cd4b-null and WT) on the
regular chow (RC) diet were injected with a 1 or 0.75 U/kg
body weight of insulin, respectively. HFD-fed male and
female mice were injected with 1.5 or 0.75 U/kg body weight
of insulin, respectively. Blood glucose levels were measured
post injection at the time points indicated. To measure insulin
secretion in vivo, animals were fasted overnight and glucose
(3 g/kg body weight) was injected into the abdomen. Blood
insulin levels were measured using an Ultra-Sensitive Mouse
Insulin ELISA Kit (90,080; Crystal Chem, Zaandam, the
Netherlands).
Measurement of circulating hormone levels For assessment of
follicle-stimulating hormone (FSH) and luteinising hormone
(LH), gonadectomy was conducted under isoflurane anaesthe-
sia [18]. Plasma levels of testosterone and oestradiol (E2) were
determined by ELISA (Enzo Life Sciences, Exeter, UK, and
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BioVision, Cambridge BioScience, Cambridge, UK, respec-
tively) 2 weeks later [18].
Insulin secretion from isolated islets Islet isolation [19] and
measurements of insulin secretion [20] were measured as
described previously, using ten size-matched islets incubated
in triplicate in HEPES-buffered Krebs-Ringer medium
(KREBH) and either 3 mmol/l glucose, 17 mmol/l glucose
or 20 mmol/l KCl at 37°C. Insulin was measured using an
Insulin Ultra-Sensitive Kit (Mercodia, Uppsala, Sweden).
Generation of C2CD4A and C2CD4B FLAG- and -green fluores-
cent protein-tagged constructs Human C2CD4A and
C2CD4B cDNA sequences were cloned in-frame into plasmid
P3XFLAG-CMV-14 (Addgene, www.addgene.org) to
provide a C-terminal 3×FLAG epitope tag. Green fluorescent
protein (GFP)-tagged proteins were generated by inserting the
human C2CD4A and C2CD4B cDNA sequences into the C-
terminus of GFP using plasmid pEGFP-C1 (Addgene).
C2CD4A/B intracellular translocation INS1(832/13) cells [21]
were grown on coverslips and transfected with either GFP-
tagged C2CD4A, C2CD4B or synaptotagmin-1 (Syt1)-
containing constructs. At 24 h post transfection, cells were
incubated for 1 h at 37°C with aerated KREBH solution.
Cells were confirmed to be mycoplasma free prior to
experiments.
Study approvalAll mouse in vivo procedures were conducted
in accordance with the UK Home Office Animal (Scientific
Procedures) Act of 1986 (Project licence PA03F7F0F to IL)
and approved by the Imperial College Animal Welfare and
Ethical Review Body. All zebrafish work was approved by
the ethical committee of the University of Liège (protocol no.
13-1557) or under European Union and German laws
(Tierschutzgesetz), and with the approval of the TU Dresden
and the Landesdirektion Sachsen (approval licence number:
TVV 45/2018).
Zebrafish maintenance and generation of transgenic lines
Zebrafish (D. rerio) were obtained from the Zebrafish
International Resource Center (Zfin, Eugene, OR, USA) or
from the European Zebrafish Resource Center at Karlsruhe
Institute of Technology (www.ezrc.kit.edu/), and then bred
at the host laboratory (University of Liège [ULg], Liège,
Belgium, or Universität Dresden, Dresden, Germany,
respectively). Genetically modified zebrafish were
developed at the host laboratories. Zebrafish were raised and
cared for according to standard protocols [22]. The transgene
rs7163757C-cfos:eGFP was constructed by introducing a
1303 bp region carrying the genome-wide association study
(GWAS)-identified gene variant rs7163757-C upstream of a
c-fos minimal promoter driving enhanced GFP (EGFP)
expression (pGW_cfos-EGFP) [23, 24] via Gateway LR
recombination (Invitrogen, Thermo Fisher Scientific,
Waltham, MA, USA). The transgene was injected into
zebrafish embryos and GFP expression patterns were analysed
during development, in adulthood and in offspring, using a
confocal microscope.
Whole-mount in situ hybridisation and immunohistochemis-
try on zebrafish embryos Double fluorescent whole-mount in
situ hybridisations were performed as previously described
[25] with the antisense RNA probe for the different genes
prepared as described [26]. Immunohistochemistry on
whole-mount embryos was performed as previously described
[27]. The proteins analysed were GFP, insulin, glucagon and
somatostatin. Images were acquired with a confocal micro-
scope and processed with ImageJ (https://imagej.nih.gov/ij/;
accessed December 2019) and figureJ (https://imagej.net/
FigureJ).
Pericardial glucose injection and live imaging in zebrafish
larvaeGlucose injection and live imaging of zebrafish primary
islets were performed as described previously [28].
Blood glucose measurements in adult zebrafish Adult
zebrafish were fasted for 24 h before glucose measurements.
For post-prandial measurements, fasted fish were fed with live
brine shrimp. Blood was collected from euthanised fish with a
microcapillary needle and glucose levels were measured using
a glucometer.
Immunofluorescence analysis of pancreatic slices Mouse
pancreases were dissected at 24 or 25 weeks of age.
Pancreases were fixed in 4% (wt/vol.) paraformaldehyde and
embedded in paraffin for the measurement of insulin and
glucagon via immunofluorescence.
Homogeneous time-resolved fluorescence (HTRF) assay The
Insulin Ultra-Sensitive Kit (ref. 62IN2PEH; Cisbio, Codolet,
France) was used according to the manufacturer’s instructions
to measure released or total insulin levels in mouse samples.
Each sample was measured in duplicate and incubated with
europium cryptate and XL665 antibodies overnight before
measuring the Fӧrster resonance energy transfer (FRET)
efficiency.
Intracellular free [Ca2+] measurements Mouse islets were
isolated and incubated with fluo2-AM (10 μmol/l; Teflabs,
Austin, TX, USA) diluted in a KREBH buffer containing 3
mmol/l glucose. Imaging was performed essentially as
described previously [29].
Whole-cell voltage-clamp electrophysiology Measurements
were performed on single beta cells isolated from wild-type
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(WT) and C2cd4b-knockout mice. Starting from a holding
potential of −80 mV, and voltage-dependent Ca2+ currents
(VDCC) currents were generated through application of
sequential 10 mV depolarising steps ranging from −70 mV
to 70 mV (500 ms).
Sample preparation for RNA sequencing Islets from five male
mice/genotype at 22 weeks of age on regular chow diet
were used for RNA purification. Generation of double-
stranded cDNA and library construction were performed
using NEBNext Ultra II Directional RNA Library Prep
Kit for Illumina (NEB, Hitchin, UK). Sequencing was
performed by the Imperial BRC Genomics Facility
(Imperial College London, UK) as 75 bp paired end
reads on a HiSeq4000 according to Illumina specifica-
tions. Data are archived in the GEO repository (www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE152576).
Quantitative reverse transcription PCR Quantitative reverse
transcription PCR (RT-qPCR) was performed in triplicate
using SYBR Green PCR Master Mix (Applied Biosystems,
Foster City, CA, USA) and primers for mouse C2cd4a and β-
actin genes.
Immunofluorescence and imaging for subcellular
localisations Rodent (MIN6 [15], INS1[832/13] [21]) or
human (EndoCβH1 [30]) beta cell lines (previously
confirmed as being mycoplasma free) were cultured for 12 h
or 24 h post transfection (with C2CD4A- or C2CD4B-FLAG
tagged constructs) and fixed in 4% (wt/vol.) paraformalde-
hyde (Sigma-Aldrich, Gillingham, Dorset, UK) before being
incubated with anti-FLAG antibodies. Images were collected
by a spinning disk microscope and a confocal inverted
microscope.
Immunoprecipitation and mass spectrometry Mycoplasma-
free MIN6 cells grown in standard culture conditions [31]
were transfected in duplicate with FLAG-tagged-C2CD4A
or -C2CD4B expressing plasmids or with a FLAG tag-only
expressing plasmid using Lipofectamine 2000 (Thermo Fisher
Scientific). Immunoprecipitation and affinity purification-MS
(AP-MS) analysis were performed, as previously described
[32], with minor modifications. The mass spectrometry prote-
omics data have been deposited to the ProteomeXchange
repository (www.ebi.ac.uk/pride/archive/projects/
PXD021597).
Statistical analysis Blinding was carried out for all mouse
in vivo experiments. Data were analysed using GraphPad
Prism 8.0 (San Diego, CA, USA; www.graphpad.com/
scientific-software/prism/, accessed 1 December 2019). A p-
value <0.05 was considered significant.
Results
C2CD4A and C2CD4B expression in mouse and human islets
Human C2CD4A and C2CD4B are 83% homologous. Like
their murine homologues, the two human genes are predicted
to have evolved from a common ancestor (see phylogenetic
tree, ESM Fig. 2a). Conservation of genomic architecture
(synteny) at this locus argues for direct homology between
the human and murine forms of each gene. The zebrafish
(D. rerio) possesses two C2cd4-like genes homologous to
H. sapiens and Mus musculus: C2cd4a and C2cd4c (ESM
Fig. 2a). Scrutiny of gene expression databases (http://
Biogps.org, accessed March 2020), and previous
publications [33, 34], reveals approximately tenfold higher
levels of C2cd4b than C2cd4a mRNA in mouse islets and
purified mouse beta cells (ESM Table 1). In contrast, roughly
equal levels of C2CD4A and C2CD4B mRNA are present in
human islets [35] and purified beta cells [36]. Expression of
both genes was detected in the pituitary in both human and
mice (data source: GTEx data, analysed in The Human Protein
Atlas; www.proteinatlas.org/ENSG00000198535-C2CD4A/
tissue and www.proteinatlas.org/ENSG00000205502-
C2CD4B/tissue; accessed November 2020). C2cd4a and
C2cd4b were both upregulated in pancreatic islets of high-
fat-diet–fed DBA2J mouse model of diabetes following 30
and 90 days of the diet vs RC-fed mice (ESM Fig. 3a,b)
[37]. No evidence of C2CD4A or C2CD4B upregulation was
observed in the islets of individuals with type 2 diabetes vs
normoglycaemic control participants [38].
Examination of the human VPS13C/C2CD4A/C2CD4B
locus revealed multiple regulatory elements (Fig. 1), consis-
tent with recent findings [9]. A SNP, rs7163757, has recently
been shown by fine mapping as the likely causal variant for
type 2 diabetes risk at this locus [9]. Correspondingly,
CRISPR activation (CRISPRa) or CRISPR interference
(CRISPRi) at the rs7163757 site has the most marked effects
on neighbouring genes [39], consistent with this being the
effector variant (SNP). To explore in more detail the potential
role of the enhancer around the diabetes risk variant
rs7163757 [9] and whether it may play a role in gene expres-
sion in disease-relevant tissues (notably the islet and brain/
pituitary), we introduced a reporter bearing 1303 bp nucleo-
tides of the human sequence into the zebrafish genome,
controlling the production of GFP from a minimal cFos
promoter (ESM Fig. 2b). Expression was restricted to the
endocrine pancreas and brain at all stages (ESM Fig. 2c,e),
and was detected in all islet cell types, most strongly in delta
cells (ESM Fig. 2d). No significant differences were seen in
the pattern of expression in embryos expressing either the C-
or the T variants, with 10% (8/80 or 10/100, respectively) of
embryos showing fluorescence in the pancreas.
Whole-mount fluorescent in situ hybridisation of 30 h-
post-fertilisation (hpf) embryos revealed that endogenous
Diabetologia
c2cd4a is expressed in the forebrain (ESM Fig. 2f), ventral
spinal cord (ESM Fig. 2g) and pancreas (ESM Fig. 2c,h).
Double fluorescent in situ hybridisation revealed presence of
the c2cd4a transcript in sst2+, ins+ and gcgb+ cells (ESM Fig.
2d,i–k).
Role of c2cd4a in the zebrafish larvae Zebrafish possess a
single gene, C2cd4a (formerly c2cd4ab), that is homologous
to the two mammalian counterparts (ESM Fig. 2a). As a
convenient proxy for insulin secretion in the larvae of fish
inactivated for c2cd4a or in WT controls (ESM Fig.4 a,b),
glucose-stimulated Ca2+ dynamics were monitored in vivo
by imaging the fluorescence of a gCaMP6 transgene.
Fasting and postprandial blood glucose levels were compara-
ble between WT and c2cd4a mutant animals (ESM Fig. 4c)
and glucose-induced Ca2+ changes did not differ between
genotypes (ESM Fig. 4d–h). These findings argue against a
role for c2cd4a in beta cell function during zebrafish
development.
Effects of C2cd4b deletion on glucose homeostasis are more
marked in female than male mice Given the substantially
higher expression of C2cd4b than C2cd4a in mouse islets
(ESM Table 1), we studied mice in which the former gene
was deleted (Fig. 2a). Inter-crossing of heterozygous animals
produced pups at the expected Mendelian ratio (Fig. 2b) and
resulted in complete elimination of C2cd4b mRNA from
isolated islets of C2cd4b−/− mice (Fig. 2c). Female C2cd4b-
null mice gained weight at the same rate as control littermates
whether maintained on RC or a HFD (Fig. 2d) and no
differences were apparent in fed or fasting blood glucose
levels either on an RC diet (ESM Fig. 5a,c) or an HFD (Fig.
2f and ESM Fig. 5e).
Beta cell mass, as assessed by histochemical analysis of
pancreatic slices, was unaffected by deletion of C2cd4b in
both females (ESM Fig. 6a–d) and males (ESM Fig. 6e–h).
Intraperitoneal glucose tolerance was examined for animals
maintained on an RC diet or HFD from 8 to 22 weeks of age.
Females displayed abnormalities at 12, 20 and 22 weeks of
age when fed an RC diet (ESM Fig. 7a,c,e,g), and at 8 and 23
weeks on an HFD (ESM Fig. 8a,c,e and Fig. 3a; p < 0.001 at
22 weeks on an HFD) vs control littermates. While oral
glucose tolerance was normal on in RC-fed female mice vs
controls (Fig. 3c), defects were observed in HFD-fed mice
(Fig. 3g). For female mice on the RC diet, these changes were
associated with defective insulin secretion in vivo (Fig. 4a;
p = 0.02), as also indicated by unchanged insulin levels after
glucose injection despite elevated plasma glucose levels in
female knockout mice maintained on an HFD (Fig. 4c).
Furthermore, insulin sensitivity was not different between
C2cd4b null and WT female mice (ESM Fig. 9a,c).
When maintained on an RC diet, male C2cd4b null mice
gained weight at the same rate asWT littermates. When main-
tained on an HFD, in contrast to females, male mutant mice
gained substantially more weight from 14weeks of age vsWT
littermates (Fig. 2d,e; p < 0.001 betwee18 and 21 weeks of
age), and had raised fasting blood glucose levels (Fig. 2g;
p = 0.03). However, significant differences in body fat and
lean mass were not apparent (Fig. 2h,i) vs WT mice.

















































Fig. 1 Genomic context of type 2
diabetes variants in the VPS13C/
C2CD4A/C2CD4B locus. SNP at
rs7163757 is located in an open
chromatin region between
C2CD4A and C2CD4B, as






data reveals binding sites for
transcription factors involved in
the development and function of
beta cells, including forkhead box
protein A2 (FOXA2), NK2
homeobox 2 (NKX2.2), NK6
homeobox 1 (NKX6.1) and
pancreatic and duodenal
homeobox 1 (PDX1). MED1,
mediator complex subunit 1.
Functional PP, functional
posterior probability. Data from
[39]
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maintained on an RC diet at most ages examined, with
genotype-dependent differences only at 16 weeks (ESM Fig.
7b,d,f,h and Fig. 3b). Although unaltered in younger male
mice after maintenance on an HFD (ESM Fig. 8b,d,f), glucose
tolerance was impaired at 23 weeks of age byC2cd4b deletion
(Fig. 3f,h) as compared with controls.
As observed in females, insulin sensitivity (ESM Fig. 9b,d)
was unaltered in male C2cd4b-null mice vs littermate controls.
Effects of C2cd4b deletion on beta cell function in vitro
Glucose-stimulated insulin secretion was not different between
islets from WT or C2cd4b-null female mice maintained on an
RC diet (ESM Fig. 10a) but was slightly elevated in those from
female null mice maintained on an HFD (ESM Fig. 10c).
Likewise, in the isolated islets from female C2cd4b-null mice,
we observed no alterations in glucose or KCl-stimulated stim-
ulated Ca2+ dynamics (ESM Fig. 11a,b) or in beta cell–beta cell
coupling (ESM Fig. 11c–f). Correspondingly, no changes in
voltage-activated Ca2+ currents were apparent in patch-clamp
recordings (ESM Fig. 12a–c).
In line with the above findings, massive parallel sequenc-
ing (RNA-Seq) of islets from C2cd4b−null or control animals
confirmed the lowering of C2cd4b expression in islets of null
mice vs WT mice, and revealed a significant (~75%) increase
in C2cd4a expression (ESM Table 2), though this was not
confirmed by independent qRT-PCR analysis (data not
shown). However, no other mRNAs were significantly affect-














































































































































































Weeks of age 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
RC C2cd4b WT - - 4 5 3 3 5 6 6 6 5 5 6 6 6 6
RC C2cd4b-/- - - 11 13 7 4 10 13 13 13 12 12 13 13 12 12
HFD C2cd4b WT 12 12 11 12 11 11 10 12 9 10 10 10 9 10 10 10
HFD C2cd4b-/- 10 10 7 10 7 7 8 10 5 8 8 8 6 8 8 8
Weeks of age 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
RC C2cd4b WT - - 12 11 11 8 8 12 12 12 10 10 12 10 8 9
RC C2cd4b-/- - - 12 10 10 10 10 12 12 12 10 10 12 10 10 12
HFD C2cd4b WT 12 12 9 11 9 9 10 12 6 10 10 10 8 8 8 8
HFD C2cd4b-/- 12 12 10 12 10 10 9 12 7 9 9 9 7 9 9 9
No. mice used: No. mice used:
Exon 2
Fig. 2 Characterisation of C2cd4b-null mice. (a) C2cd4b global null
mice (C2cd4bem2Wtsi) were generated by the IMPC. Using CRISPR/
Cas9, the encoding exon from murine C2cd4b (exon 2) was deleted. (b)
C2cd4b+/− (heterozygous) animals were setup as breeding pairs and the
WT (C2cd4b+/+) and homozygous (C2cd4b−/−) littermates were studied.
(c) RT-qPCR was performed on RNA from isolated islets and showed a
significant decrease in C2cd4b mRNA levels in homozygous animals
(p=0.0092). C2cd4b+/+ n=4, C2cd4b+/− n=3, C2cd4b−/− n=7.
**p<0.01, unpaired Student’s t test. (d, e) Changes in weight of
C2cd4b+/+ and C2cd4b−/− female (d) and male (e) mice over time on
an RC diet or HFD. RC: female (F)+/+ n=3–6; F−/− n=4–13; male (M)+/+
n=8–12; M−/− n=10–12. HFD: F+/+ n=9–12, F−/− n=5–10–12; M+/+ n=6–
12, M−/− n=7–12. (f, g) Fasting blood glucose level in female (f) and male
(g) mice on an HFD were measured at 23 weeks of age. F+/+ n=9; F−/−
n=5; M+/+ n=5; M−/− n=7. (h, i) Percentage of body fat (h) and lean mass
(i) in males maintained on an HFD at 20 weeks of age. *p<0.05,
**p<0.01, ***p<0.001, mixed-effect analysis, RC-fed WT vs RC-fed
mutant mice or HFD-fedWT vs HFD-fed mutant mice at each time point
(d, e), or Student’s t test (c, f–i). Data were assessed for significance using
an unpaired Student’s t test or two-way ANOVA where two genotypes
were compared. Values represent means ± SEM
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Glucose or KCl-stimulated insulin secretion from isolated
islets were also unaltered in male C2cd4b-null mice vs litter-
mate controls (ESM Fig. 10 b,d).
Effects of C2cd4b deletion on pituitary function Given the
absence of clear defects in insulin secretion in isolated
C2cd4b-null islets, and the expression of both C2cd4a and
C2cd4b in the pituitary (data source: GTEx data, analysed in
The Human Protein Atlas; www.proteinatlas.org/
ENSG00000198535-C2CD4A/tissue and www.proteinatlas.
org/ENSG00000205502-C2CD4B/tissue; Fig. 5a), we next
assessed whether deletion of this gene might affect the
production of sex hormones and, thus, provoke gender-
specific differences in glucose homeostasis. E2 and testoster-
one levels were unaltered in both male and female C2cd4b-
null mice maintained on an RC diet or HFD vs WT animals
(Fig. 5b,c). In order to remove the negative feedback loop
through which hormones secreted from the gonads repress
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Fig. 3 C2cd4b-null mice display glucose intolerance in glucose tolerance
tests (IPGTTs/OGTTs). (a, b) IPGTTs were performed on female (a) and
male (b) mice maintained on an RC diet, at 22 weeks of age. (c, d)
OGTTs were performed on C2cd4b-null and WT female (c) and male
(d) mice on an RC, at 20 weeks of age. (e, f) IPGTTs were performed on
C2cd4b-null and WT female (e) and male (f) mice maintained on an
HFD, at 23 weeks of age. (g, h) OGTTs were performed on C2cd4b
female (g) and male (h) mice on an HFD, at 20 weeks of age. AUC
analyses are also shown. The n values under bar graphs represent the
number of animals used (the same number of samples were used for blood
glucose and AUC graphs). *p<0.05, **p<0.01, ***p<0.001 vs mutant
animal at same time point or as indicated. Blood glucose curves assessed
by two-way ANOVA with Bonferroni’s multiple comparison test; AUC
analyses assessed using an unpaired Student’s t test. Values represent
means ± SEM
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FSH and LH release from the pituitary gland, animals between
12 and 15 weeks of age were gonadectomised prior to these
experiments. Compared withWT littermates, female C2cd4b-
null mice displayed ~50% lower circulating FSH levels, with
no difference in LH levels (Fig. 5d,f; p = 0.003). No differ-
ences in LH or FSH levels were apparent between WT and
C2cd4b-null male mice (Fig. 5e,g).
C2cd4a-null mice display no metabolic abnormalities To
determine whether C2cd4a inactivation might also have an
impact on glucose homeostasis, we next examined metabolic
phenotypes in male and female C2cd4a-null mice (ESM Fig.
13a–c). In contrast to theirC2cd4b-null counterparts,C2cd4a-
null mice displayed no evident metabolic abnormalities up to
22 weeks of age, with neither weight gain, glucose homeosta-
sis nor insulin secretion differing between WT and null mice
for either sex (ESM Fig. 13d–i). Likewise, as measured
in vitro, glucose and KCl (depolarisation)-stimulated insulin
secretion were unaltered in islets isolated from male C2cd4a-
null mice (ESM Fig. 13j).
C2CD4A but not C2CD4B C2 domains support Ca2+-depen-
dent intracellular translocation We next sought to explore
the mechanism(s) through which C2CD4B or C2CD4A may
influence beta cell (and, potentially, pituitary gonadotroph)
function. Both proteins have been suggested to lack a func-
tional C2 domain [11], consistent with a reported localisation
in the nucleus in COS7 cells [10]. In contrast to earlier find-
ings reporting nuclear subcellular localisation, when
overexpressed as GFP- or FLAG- tagged chimaeras in rodent
(MIN6, INS1[832/13]) or human (EndoCβH1) beta cell
lines, C2CD4A and C2CD4B were found at the plasma
membrane and in the cytosol and the nucleus (ESM
Fig.14 and ESM Fig.15). In the majority of cells,
C2CD4A and C2CD4B were primarily localised to the
cytoplasm and nucleus. Co-localisation with readily iden-
tified intracellular sub-compartments, including the secre-
tory granule (insulin), trans-Golgi network (TGN46),
endosome/lysosome (LAMP1) or endoplasmic reticulum
(ER; KDEL), was not apparent in the above cell lines
(ESM Fig. 16; data only shown for MIN6 cells but
results were consistent in all three cell lines).
The above findings suggested that the C2 domain of either
protein may bind to Ca2+ and contribute to localisation at, and/
or shuttling between, subcellular compartments in living cells.
To test this hypothesis, we explored phospholipid-dependent
recruitment of these proteins to the plasma membrane in
INS1(832/13) beta cells [21] expressing either a control
construct, in which Syt1 (bearing five C2 domains) was fused
to GFP [40] or equivalent C2CD4A or C2CD4B constructs
(N-terminal linkage). In response to an increase in intracellular
free Ca2+, provoked by 50 μmol/l extracellular Ca2+ and the
calcium ionophore ionomycin (50 ng/ml), Syt1–GFP
translocated from intracellular (likely ER-bound) sites to the
plasma membrane. This movement was readily visualised by
simultaneous live-cell wide-field and total internal reflection
of fluorescence (TIRF) imaging (Fig. 6a,b,d). A similar, but
smaller change in the localisation of C2CD4A–GFP in
response to Ca2+ was also observed. In contrast, no response































































































































































































Fig. 4 Effect of C2cd4b deletion on in vivo glucose-stimulated insulin
secretion. (a–d) In vivo insulin levels during IPGTT in C2cd4b-null and
WT females (a, c) and males (b, d) on an RC diet, at 23 weeks of age (a,
b) or an HFD at 19 weeks of age (c, d). RC: female (F)+/+ n=9; F−/− n=6;
male (M)+/+ n=6; M−/− n=7. HFD: F+/+ n=5; F−/− n=7; M+/+ n= 7; M−/−
n=7. *p<0.05, ***p<0.001, WT vs mutant animal at same time point,
two-way ANOVA with Bonferroni’s multiple comparison test. Values
represent mean ± SEM
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Identification of C2CD4A and C2CD4B binding partners by
mass spectrometry The above experiments demonstrated that
C2CD4A, and possibly C2CD4B, may participate in Ca2+-
dependent signal transduction. To gain further insight into
possible mechanisms of action, we performed an unbiased
proteomic screen using immunoprecipitation and mass spec-
trometry to identify potential binding partners. Normalising to
the negative control, and ranking in order of protein abun-
dance, we generated lists of possible interacting proteins for
human C2CD4A, C2CD4B (ESM Tables 3,4) or both (ESM
Table 5). MIN6 cells transfected with human C2CD4A or
C2CD4B were used for this analysis, given the low transfec-
tion efficiency of human-derived EndoCβH1 cells.
Interacting partners included proteins involved in Ca2+ bind-
ing (torsin-2A [TOR2A] and EF-hand calcium-binding
domain-containing protein 5 [EFCAB5; [41] and www.
genecards.org/), NF-κB signalling (sequestosome-1




























































































































































Fig. 5 Effect of deletion of C2cd4b on sex hormones and hormone
release from the pituitary gland. (a) RT-qPCR on samples from the pitu-
itary glands shows basal level of mRNA expression ofC2cd4b in animals
deleted for this gene compared with WT mice. (b, c) Measurement of E2
and testosterone levels upon deletion of C2cd4b in female and male mice
maintained on either an RC diet or an HFD. (d, e) Circulating LH levels in
C2cd4b-null and WT female (d) and male (e) mice after injections with
saline (154 mmol/l NaCl; vehicle), E2 or testosterone (animals were
maintained on an RC diet). (f, g) Circulating FSH levels in C2cd4b-null
andWT female (f) andmale (g) mice after injections with saline (vehicle),
E2 or testosterone (animals were maintained on an RC diet). Female
(F)+/+ n=6, F−/− n=5; male (M)+/+ n=4; M−/− n=5. **p<0.01,
***p<0.001, unpaired Student’s t test. Values represent mean ± SEM
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[PDCD11]) and protein trafficking (proprotein convertase
subtilisin/kexin type 9 [PCSK9], neural precursor cell
expressed, developmentally down-regulated 4, E3 ubiquitin
protein ligase [NEDD4], Ras-proximate-1 [Rap1] and
GTPase-activating protein [GAP2]). Receptor-type tyrosine-
protein phosphatase-like N (PTPRN; insulinoma-associated
protein 2 [IA-2]) and PTPRN2; phogrin/IA-2β/islet cell anti-
gen 512 [ICA512]) bound to both C2CD4A and C2CD4B.
These protein tyrosine phosphatase-like transmembrane
proteins are granule-resident and implicated in granule traf-
ficking and exocytosis [42].
Discussion
The overall aim of this study was to examine the biological
roles of C2cd4b and C2cd4a in vivo, focusing on the pancre-
atic beta cell and pituitary gland. These questions have been
pursued using mouse and fish knockout models and relevant
cell lines. In contrast to earlier findings [15], we observed that
global C2cd4a deletion in the mouse exerted no effects on
insulin secretion in vitro or in vivo. These findings are consis-
tent with the considerably (tenfold) lower expression of
C2cd4a than C2cd4b in mouse islets and mouse-derived beta
cell lines (ESM Table 1), though we should emphasise that no
attempt was made here to quantify protein (rather than
mRNA) levels. The reasons for the differences between the
present study and that of Kuo et al [15] with respect toC2cd4a
are presently unclear.
Deletion of C2cd4b leads to weight gain in males, but defec-
tive insulin secretion in female mice Our findings reveal a
strikingly sexually dimorphic phenotype of C2cd4b-null
mice, which is also strongly dependent upon diet. In contrast
to females, maleC2cd4b null mice displayed no evident meta-
bolic abnormalities at most ages when maintained on an RC
diet. Although mutant male mice exhibited a substantial
increase in body weight on the HFD, fasting glucose and
glucose tolerance were impaired only in older (>20 weeks)
animals. In stark contrast, female mutant mice displayed
abnormal glucose tolerance from as early as 12 weeks when
fed an RC diet and 8 weeks when fed an HFD (with a tenden-
cy towards abnormal glucose tolerance [p > 0.05] being
observed at 8 weeks in RC-fed mice), despite unaltered body
weight. Non-significant changes in lean mass were observed
in male C2cd4b-null mice on HFD, which are reminiscent of
findings from the IMPC (www.mousephenotype.org/data/
genes/MGI:1922947, accessed November 2020) when this
line was fed an RC diet. The mechanisms underlying these
changes remain unclear but are unlikely to involve elevated
testosterone levels in knockout animals, since these were not
observed in our study.
Although earlier human studies were not stratified by sex,
we note that a statistically significant (p = 0.004) impact of the
human type 2 diabetes-associated variant rs7172432 (which is
in perfect linkage disequilibrium with rs7163757: R2 = 1.0)
[15] at the VPS13C/C2CD4A/C2CD4B locus on waist
circumference has previously been reported [43], and may
be related to the alterations in body weight we observed here
in male C2cd4b-knockout mice.
What factors underlie these sex-dependent differences
in insulin secretion between WT and C2cd4b-null mice?
Our findings suggest that beta cell-extrinsic mechanisms,
possibly involving circulating factors, contribute to (and
may even be the drivers of) altered insulin secretion in
the living animal. Potential contributors are changes in
FSH levels [44, 45] in female C2cd4b-null mice, reflecting
altered expression of the gene in the pituitary. Decreased
FSH production is expected, in turn, to decrease circulating
oestrogen levels. We note, however, that measurements of
oestrogen are complicated in fertile mice due to fluctua-
tions in the oestrous cycle [46]. Positive actions of
oestrogen on beta cell insulin content (via oestrogen recep-
tor α) and secretion (via oestrogen receptor β) are well
known [44, 47] and may thus underlie the weaker insulin
secretion in C2cd4b-knockout mice. Consistent with a
requirement for sexual maturity, no differences were
apparent in beta cell function between genotypes in the
living fish embryo (ESM Fig.4) at stages where differences
in circulating sex hormones are not anticipated, and fasting
blood glucose levels did not differ between WT and knock-
out fish at adult stages. These findings are in contrast to
earlier studies in zebrafish larvae using oligonucleotide-
mediated C2cd4a gene knockdown [13], which reported
alterations in beta cell mass.
Such sexual dimorphism on the impact of variants at this
locus, however, has not been reported in human GWAS data
[48, 49]. One possible explanation is that dimorphism in mice
reflects well-known differences in the response of males and
females to HFD [50].More likely, in our view, is that in rodent
islets (and pituitary; see below), C2cd4b expression predom-
inates over C2cd4a, while in humans, C2CD4A and C2CD4B
expression are comparable. Consequently, in humans, chang-
es in both C2CD4A and C2CD4B may mediate the effect of
the GWAS signal for type 2 diabetes, dampening a sexually
dimorphic effect of changes in C2CD4B expression.
Might altered genetic risk for type 2 diabetes in humans
result from changes inC2CD4A orC2CD4B expression in the
brain? Importantly, high levels of expression of C2CD4A and
C2CD4B in the pituitary (GTEx data, The Human Protein
Atlas; www.proteinatlas.org/ENSG00000198535-C2CD4A/
tissue and www.proteinatlas.org/ENSG00000205502-
C2CD4B/tissue; accessed November 2020) are consistent
with this view. Correspondingly, an eQTL for C2CD4A is
reported for rs7163757 in the pituitary (www.gtexportal.org/
Diabetologia
home/snp/rs7163757#sqtl-block, accessed November 2020),
with a (non-significant) tendency towards decreased expres-
sion of C2CD4A and, more strongly, VPS13C in carriers of C
(risk allele) vs T alleles.
Intracellular signalling by C2cd4a and C2cd4b Our observa-
tion that neither C2CD4A nor C2CD4B are localised exclusive-
ly in the nucleus, as previously reported in COS7 cells [10], islets
and MIN6 cells [15], was unexpected, but implies a more
e



























































































































































































dynamic role for both C2CD4A, and possibly C2CD4B, in
intracellular signalling. We note that the present study explored
the subcellular distribution of the H. sapiens protein, rather than
the M. musculus homologue examined previously [15], provid-
ing a potential explanation for these differences. Interestingly,
predictions from the primary structure [11] indicate that neither
C2CD4A nor C2CD4B (human or mouse) possesses a C2
domain with a bona fide Ca2+-binding site [51, 52].
Nevertheless, we provide a direct demonstration of Ca2+-depen-
dent recruitment of C2CD4A to the plasma membrane (Fig. 6),
whereas C2CD4B would appear to exert its function indepen-
dently of Ca2+ binding.
What signalling mechanism(s) may lie downstream of
C2CD4A (or C2CD4B)? The interacting protein PTPRN2
(also known as phogrin and IA-2β) is of particular interest
[42]. Inactivation of PTPRN2/phogrin, a secretory granule-
localised protein [53], leads to defective insulin secretion in
mice [54, 55]. Importantly, double knockout of PTPRN2/
phogrin and the closely-related Ptprn (IA-2) gene leads to
defective FSH and LH production and female infertility
[54], implying an important role in the anterior pituitary. An
interaction between C2CD4A or C2CD4B and PTPRN2 in
the pituitary (and possibly the beta cell) may, therefore,
contribute to the effects of altered expression on diabetes risk.
Limitations of the study The present work was undertaken
using animals on a mixed C57BL6N:C57BL6J background
and future studies are required to confirm the findings here in
pure-bred strains [56]. The impact of C2cd4b deletion on fertil-
ity, and on the role of C2cd4a and C2cd4b in the pituitary,
remain to be explored, as does the contribution of changes in
food intake or energy expenditure to differences in body
weight. More work will also be necessary to determine whether
c2cd4a-null zebrafish display beta cell deficiency.
Restrictions imposed by the coronavirus disease-2019
(COVID-19) pandemic prevented further explorations of
these points during the present study.
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Fig. 6 Changes in C2CD4A and C2CD4B localisation in response to
increased intracellular [Ca2+]. (a) Schematic showing the principle of
Ca2+-dependent translocation of C2 domains to the plasma membrane.
The ribbon diagram reproduced from [57] under the terms of the Creative
Commons Attribution 4.0 International License (http://creativecommons.
org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium. (b) Localisation of GFP-Syt1 in cells
incubated in KREBH buffer with 3 mmol/l glucose, shown before and
after an increase in intracellular Ca2+ levels (achieved by addition of 50
ng/ml ionomycin), obtained by simultaneous wide-field and TIRF image
acquisition (positive control). (c) Localisation of GFP-tagged C2CD4A
and -C2CD4B before and after addition of ionomycin, obtained by
simultaneous wide-field and TIRF image acquisition. (d, f) Time
courses for the translocation of the GFP-tagged proteins, Syt1 (d),
C2CD4A (e) or C2CD4B (f) obtained by TIRF imaging before and
after addition of ionomycin (iono). (d–f) Solid black lines represent
mean; SEM shown by grey bars. (g) Assessment of fluorescence
intensity change (%) reveals an increase in C2CD4A intensity at the
plasma membrane after the imposed increase in intracellular Ca2+
levels, which was similar to that observed for Syt1 protein
translocation, whilst C2CD4B translocation was significantly lower
than Syt1. For each condition, n=3 independent experiments were
performed; n=44 cells were tracked in Syt1, n=29 cells were tracked in
the case of C2CD4A, and n=30 cells were tracked in the case of
C2CD4B. Scale bars = 10 μm. **p<0.01, one-way ANOVA
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